Press release
Global Nucleic Acid Amplification Testing Market Size Expected To Reach USD 24.5 Billion With CAGR 12.8% By 2032 : Report by GIS
The nucleic acid amplification testing (NAAT) market has experienced rapid growth, driven by the increasing demand for accurate and rapid diagnostic tools in infectious disease detection and molecular diagnostics. NAAT techniques, such as polymerase chain reaction (PCR), loop-mediated isothermal amplification (LAMP), and nucleic acid sequence-based amplification (NASBA), have revolutionized pathogen detection by enabling the amplification of target DNA or RNA sequences, even in minute quantities, facilitating highly sensitive and specific detection of pathogens.Request for Free Sample @ https://www.globalinsightservices.com/request-sample/GIS10512/?utm_source=SnehaPatil&utm_medium=Openpr&utm_campaign=06122023
This technology's versatility spans across various applications, including infectious disease diagnosis, oncology, genetic testing, and research. The market's expansion is further fueled by continuous technological advancements, automation, and the development of portable, point-of-care NAAT devices, driving accessibility to accurate and timely molecular diagnostic solutions for healthcare providers worldwide. Additionally, the ongoing focus on the early detection of infectious diseases and the need for rapid and precise diagnostic tools during public health emergencies have positioned NAAT as a cornerstone in modern diagnostics, playing a pivotal role in disease management and control strategies.
Key Trends
An influential trend shaping the nucleic acid amplification testing (NAAT) market is the increasing adoption of point-of-care (POC) and near-patient testing solutions. This trend signifies a significant shift towards decentralized testing methodologies, enabling rapid and on-site detection of infectious diseases and other molecular diagnostics. POC NAAT devices offer the advantage of delivering quick and accurate results within shorter time frames, reducing the reliance on centralized laboratory facilities and allowing for immediate clinical decision-making. The growing demand for timely diagnosis, particularly in remote or resource-limited settings, drives the development of compact, user-friendly NAAT platforms that provide reliable molecular testing at the point of need. Furthermore, advancements in miniaturization, automation, and connectivity technologies are contributing to the evolution of portable and handheld NAAT devices, fostering their integration into various healthcare settings and expanding access to molecular diagnostics beyond traditional laboratory environments.
Read Full Research Report @ https://www.globalinsightservices.com/reports/nucleic-acid-amplification-testing-market/?utm_source=SnehaPatil&utm_medium=Openpr&utm_campaign=06122023
Key Drivers
A primary driver fueling the growth of the nucleic acid amplification testing (NAAT) market is the increasing demand for accurate and rapid diagnostic solutions across diverse healthcare settings. NAAT techniques, such as PCR and other amplification methods, offer high sensitivity and specificity in detecting infectious diseases, genetic disorders, and cancer biomarkers. This heightened demand is propelled by the growing prevalence of infectious diseases worldwide, necessitating precise and timely diagnoses for effective patient management. Additionally, advancements in NAAT technologies, including automation, multiplexing capabilities, and the development of more user-friendly platforms, have facilitated streamlined testing workflows, contributing to enhanced efficiency and broader adoption in clinical laboratories.
Buy Now@ https://www.globalinsightservices.com/checkout/single_user/GIS10512/?utm_source=SnehaPatil&utm_medium=Openpr&utm_campaign=06122023
Market Segmentation : Nucleic Acid Amplification Testing Market
Nucleic Acid Amplification Testing Market By Type : Polymerase Chain Reaction (PCR) tests, Isothermal Nucleic Acid Amplification Technology (INAAT) tests, Ligase Chain Reaction (LCR) tests
Nucleic Acid Amplification Testing Market By Application : Infectious Disease Testing, Oncology Testing, Genetic & mitochondrial disease testing, Others
Nucleic Acid Amplification Testing Market By End-use : Hospitals, Central and reference laboratories, Others
Nucleic Acid Amplification Testing Market By Region : North America : US, Canada, Mexico, Europe : The UK, Germany, France, Italy, Spain, Netherlands, Switzerland, Asia-Pacific : China, India, Japan, South Korea, Australia, Singapore, Indonesia, Rest of Asia-Pacific, Rest of the World : Latin America, Middle East, Africa
Key Players :
F. Hoffmann-La Roche Ltd
Becton, Dickinson and Company
Danaher Corporation
Abbott Laboratories
Illumina, Inc.
Siemens Healthineers
bio Mérieux SA
Novartis AG
Bio-Rad Laboratories, Inc.
See gene Inc.
Request for Customization @ https://www.globalinsightservices.com/request-customization/GIS10512/?utm_source=SnehaPatil&utm_medium=Openpr&utm_campaign=06122023
With Global Insight Services, you receive :
10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology
Contact Us :
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 15998
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
About Global Insight Services :
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Nucleic Acid Amplification Testing Market Size Expected To Reach USD 24.5 Billion With CAGR 12.8% By 2032 : Report by GIS here
News-ID: 3317399 • Views: …
More Releases from Global Insight Services

Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing …
The Immuno Oncology Drugs Market is rapidly emerging as a transformative segment in the global healthcare industry. These drugs harness the body's immune system to identify and attack cancer cells, offering innovative treatment alternatives to traditional chemotherapy and radiation therapies. Immuno-oncology therapies include monoclonal antibodies, checkpoint inhibitors, cancer vaccines, and cell-based therapies such as CAR-T cells. The growth of this market is primarily driven by advancements in biotechnology, an improved…

GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Ove …
The GLP 1 Market is experiencing unprecedented growth, fueled by the rising prevalence of type 2 diabetes and obesity globally. GLP-1, or glucagon-like peptide-1 receptor agonists, represents a groundbreaking therapeutic class that improves insulin secretion, reduces glucagon production, and slows gastric emptying. These mechanisms not only enhance glycemic control but also support weight management, making GLP-1 therapies a preferred choice among healthcare providers and patients alike. Over the years, the…

Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAG …
Market Overview
Autonomous Bus Market is revolutionizing the future of urban mobility through advanced automation technologies. Valued at $2.1 billion in 2024, the market is projected to reach $11.6 billion by 2034, expanding at a strong CAGR of 18.8%. This market focuses on the development and deployment of self-driving buses equipped with cutting-edge sensors, artificial intelligence, and vehicle-to-everything (V2X) communication systems. These buses are designed to improve road safety, enhance passenger…

Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | …
Market Overview
Automotive Tire Market is experiencing remarkable growth as the industry embraces innovation, sustainability, and digital transformation. Valued at $406 billion in 2024, the market is projected to soar to $976.7 billion by 2034, reflecting a CAGR of 9.2%. This expansion is primarily driven by the surge in global vehicle production, growing consumer preference for durable and high-performance tires, and the increasing adoption of smart tire technologies. The Automotive Tire…
More Releases for NAAT
Global NAAT Market Set to Nearly Double by 2032: Innovations Drive Rapid Diagnos …
Complete Report: https://www.alliedmarketresearch.com/nucleic-acid-amplification-testing-market-A180240
The global nucleic acid amplification testing (NAAT) market is witnessing unprecedented momentum, propelled by a surge in infectious diseases and groundbreaking advances in molecular diagnostics. Valued at $4.8 billion in 2022, the market is projected to soar to $9.1 billion by 2032, growing at a CAGR of 6.6%.
NAAT is a sophisticated diagnostic tool that amplifies DNA or RNA from patient samples - such as blood, urine, or tissue…
Market Resurgence: Nucleic Acid Amplification Testing (NAAT) Market Influence on …
𝐆𝐫𝐨𝐰𝐭𝐡 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬, a renowned Market analysis authority, has recently released its latest report on the 𝐍𝐮𝐜𝐥𝐞𝐢𝐜 𝐀𝐜𝐢𝐝 𝐀𝐦𝐩𝐥𝐢𝐟𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 (𝐍𝐀𝐀𝐓) 𝐌𝐚𝐫𝐤𝐞𝐭. Crafted through primary interviews and secondary research methodology, the report delves into detailed insights on product pricing trends, Market drivers, and potential opportunities from 𝟐𝟎𝟐𝟒 𝐭𝐨 𝟐𝟎𝟑𝟐. It also addresses Market challenges and threats faced by companies.
𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞:
The report furnishes information about companies, encompassing product details, sales volume,…
Molecular Point Of Care Testing (Using NAAT) Market Growth Health Infrastructure …
Description
On the other hand, the increased healthcare expenditure and emerging countries with developed hospitals act as an opportunity to grow the global molecular point of care testing (using NAAT) market. molecular point of care testing (using NAAT) market is expected to reach USD 62,553.67 million by 2029 , from USD 25,170.05 million in 2020, growing at the CAGR of 10.8% in the forecast period of 2021 to 2029 .…
Molecular Point Of Care Testing (Using NAAT) Market Industry Analysis, Key Vendo …
Description
On the other hand, the increased healthcare expenditure and emerging countries with developed hospitals act as an opportunity to grow the global molecular point of care testing (using NAAT) market. molecular point of care testing (using NAAT) market is expected to reach USD 62,553.67 million by 2029 , from USD 25,170.05 million in 2020, growing at the CAGR of 10.8% in the forecast period of 2021 to 2029 . The…
NA Molecular Point Of Care Testing (Using NAAT) Market Size, Share, Industry, Fo …
The NA Molecular Point Of Care Testing (Using NAAT) Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global NA Molecular Point Of Care Testing (Using NAAT) market. This report explores all the…
Global Molecular Point Of Care Testing (Using NAAT) Market Size, Share, Industry …
The Global Molecular Point Of Care Testing (Using NAAT) Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Global Molecular Point Of Care Testing (Using NAAT) market. This report explores all the…